TTD | Drug: D0I5ZM

Drug General Information
Drug ID	D0I5ZM
Former ID	DIB009235
Drug Name	Remogli ozin-etabonate
Indication	Type 2 diabetes [ICD9: 250; ICD10:E11]		Phase 2	[550338]
Company	Bhv pharma
Target and Pathway
Target(s)	Sodium/glucose cotransporter 2	Target Info	Modulator	[532334]
Reactome	Hexose transport
	Na+-dependent glucose transporters
	Inositol transporters
WikiPathways	NRF2 pathway
References
Ref 550338	Clinical pipeline report, company report or official report of Bhv pharma.
Ref 532334	Safety, pharmacokinetics and pharmacodynamics of remogliflozin etabonate, a novel SGLT2 inhibitor, and metformin when co-administered in subjects with type 2 diabetes mellitus. BMC Pharmacol Toxicol.2013 Apr 30;14:25.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.

Drug Information